Anuradha Roy

Prof. Anuradha Roy

Department of Management Science and Statistics, the University of Texas at San Antonio, San Antonio, TX 78249, USA

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Journal of Biomechanics
Verified
Journal Article
Closed access
JNJeffry S. Nyman
Jeffry S. Nyman
Anuradha RoyAnuradha Roy
Anuradha Roy
XSXinmei Shen
Xinmei Shen
RARae L. Acuna
Rae L. Acuna
JTJerrod H. Tyler
Jerrod H. Tyler
XWXiaodu Wang
Xiaodu Wang

31 January 2007 in Journal of Orthopaedic Research
Verified
Journal Article
Open access
PDF file
JNJeffry Nyman
Jeffry Nyman
Anuradha RoyAnuradha Roy
Anuradha Roy
JTJerrod H. Tyler
Jerrod H. Tyler
RARae L. Acuna
Rae L. Acuna
HGHeather J. Gayle
Heather J. Gayle
XWXiaodu Wang
Xiaodu Wang
The risk of bone fracture depends in part on tissue quality, not just the size and mass. This study assessed the postyield energy dissipation of cortical bone in tension as a function of age and composition. Specimens were prepared from tibiae of human cadavers in which male and female donors were divided into two age groups: middle aged (51 to 56 years, n = 9) and elderly (72 to 90 years, n = 8). By loading, unloading, and reloading a specimen with rest periods inserted in between, tensile properties at incremental strain levels were assessed. In addition, postyield toughness was estimated and partitioned as plastic strain energy related to permanent deformation, released elastic strain energy related to stiffness loss, and hysteresis energy related to viscous behavior. Porosity, mineral and collagen content, and collagen crosslinks of each specimen were also measured to determine the micro‐ and ultrastructural properties of the tissue. Age affected all the energy terms plus strength but not elastic stiffness. The postyield energy terms were correlated with porosity, pentosidine (a marker of nonenzymatic crosslinks), and collagen content, all of which varied significantly with age. General linear models suggested that pentosidine concentration and collagen content provided the best explanation of the age‐related decrease in the postyield energy dissipation. Among them, pentosidine concentration had the greatest contribution to plastic strain energy and was the best explanatory variable of damage accumulation. © 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 25:646–655, 2007


1 July 2004 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
MBMousumi Banerjee
Mousumi Banerjee
JGJulie George
Julie George
ESEun Young Song
Eun Young Song
Anuradha RoyAnuradha Roy
Anuradha Roy
WHWilliam Hryniuk
William Hryniuk
To define prognostic groups for recurrence-free survival in breast cancer, assess relative effects of prognostic factors, and examine the influence of treatment variations on recurrence-free survival in patients with similar prognostic-factor profiles. We analyzed 1,055 patients diagnosed with stage I-III breast cancer between 1990 and 1996. Variables studied included socioeconomic factors, tumor characteristics, concurrent medical conditions, and treatment. The primary end point was recurrence-free survival (RFS). Multivariable analyses were performed using recursive partitioning and Cox proportional hazards regression. The most significant difference in prognosis was between patients with fewer than four and those with at least four positive nodes (P < .0001). Four distinct prognostic groups (5-year RFS, 97%, 78%, 58%, and 27%) were developed, defined by the number of positive nodes, tumor size, progesterone receptor (PR) status, differentiation, race, and marital status. Patients with fewer than four positive nodes and tumor ≤ 2 cm, PR positive, and well or moderately differentiated had the best prognosis. RFS in this group was unaffected by type of adjuvant therapy (P = .38). Patients with at least four positive nodes and PR-negative tumors had the worst prognosis, and those treated with tamoxifen plus chemotherapy had the best outcome in this group (P = .0001). Among patients in the two intermediate-risk groups, those treated with tamoxifen or a combination of tamoxifen and chemotherapy had the best outcome. Lymph node status, PR status, tumor size, differentiation, race, and marital status are valuable for prognostication in breast cancer. The prognostic groups derived can provide guidance for clinical trial design, patient management, and future treatment policy.

1 December 2006 in Bone
Verified
Journal Article
Closed access
JNJeffry S. Nyman
Jeffry S. Nyman
Anuradha RoyAnuradha Roy
Anuradha Roy
RARae L. Acuna
Rae L. Acuna
HGHeather J. Gayle
Heather J. Gayle
MRMichael J. Reyes
Michael J. Reyes
Xiaodu WangXiaodu Wang
Xiaodu Wang

1 December 2005 in Statistical Methodology
Verified
Journal Article
Closed access
Anuradha RoyAnuradha Roy
Anuradha Roy
RKRavindra Khattree
Ravindra Khattree